Progyny Quarterly Balance Sheets Chart
Quarterly
|
Annual
Progyny Quarterly Balance Sheets Table
Quarterly
|
Annual
| Unit: USD | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| assets | ||||||||||||||||||||||||
| current assets: | ||||||||||||||||||||||||
| cash and cash equivalents | 132,506,000 | 109,239,000 | 162,314,000 | 91,480,000 | 94,960,000 | 114,959,000 | 97,296,000 | 158,075,000 | 170,570,000 | 155,320,000 | 120,078,000 | 72,520,000 | 54,730,000 | 38,821,000 | 91,413,000 | 92,224,000 | 48,747,000 | 29,820,000 | 70,305,000 | 53,965,000 | 49,392,000 | 91,634,000 | 80,382,000 | 7,664,000 |
| marketable securities | 172,586,000 | 146,884,000 | 65,640,000 | 144,240,000 | 167,228,000 | 256,872,000 | 273,791,000 | 177,477,000 | 111,925,000 | 52,569,000 | 69,222,000 | 68,473,000 | 67,655,000 | 66,855,000 | 28,005,000 | 22,086,000 | 45,221,000 | 77,095,000 | 38,994,000 | 50,995,000 | 41,984,000 | |||
| accounts receivable, net of 54,452 and 56,355 of allowance at june 30, 2025 and december 31, 2024, respectively | 271,853,000 | |||||||||||||||||||||||
| prepaid expenses and other current assets | 17,457,000 | 11,826,000 | 9,443,000 | 29,858,000 | 26,259,000 | 12,472,000 | 27,451,000 | 6,954,000 | 13,677,000 | 5,945,000 | 4,489,000 | 2,838,000 | 4,129,000 | 5,230,000 | 4,564,000 | 4,933,000 | 3,756,000 | 4,218,000 | 5,259,000 | 1,328,000 | 3,333,000 | 4,442,000 | 5,003,000 | 1,337,000 |
| total current assets | 594,402,000 | 567,692,000 | 472,721,000 | 546,302,000 | 582,243,000 | 681,512,000 | 640,407,000 | 611,272,000 | 561,130,000 | 527,079,000 | 433,856,000 | 401,866,000 | 356,378,000 | 309,026,000 | 258,539,000 | 254,424,000 | 238,491,000 | 227,799,000 | 190,222,000 | 184,590,000 | 159,705,000 | 161,938,000 | 132,444,000 | 53,338,000 |
| property and equipment | 19,943,000 | 15,740,000 | 12,383,000 | 11,928,000 | 10,637,000 | 10,234,000 | 10,213,000 | 9,716,000 | 9,497,000 | 8,883,000 | 8,371,000 | 7,201,000 | 6,276,000 | 5,827,000 | 5,027,000 | 4,702,000 | 3,931,000 | 3,583,000 | 3,400,000 | 3,506,000 | 3,604,000 | 3,673,000 | 3,083,000 | 973,000 |
| operating lease right-of-use assets | 26,423,000 | 26,949,000 | 17,251,000 | 17,439,000 | 17,806,000 | 17,181,000 | 17,605,000 | 18,028,000 | 18,451,000 | 18,872,000 | 6,903,000 | 7,132,000 | 7,359,000 | 7,583,000 | 7,805,000 | 8,024,000 | 8,241,000 | 8,456,000 | 8,668,000 | |||||
| goodwill | 19,963,000 | 19,651,000 | 15,534,000 | 15,796,000 | 15,606,000 | 11,880,000 | 11,880,000 | 11,880,000 | 11,880,000 | 11,880,000 | 11,880,000 | 11,880,000 | 11,880,000 | 11,880,000 | 11,880,000 | 11,880,000 | 11,880,000 | 11,880,000 | 11,880,000 | 11,880,000 | 11,880,000 | 11,880,000 | 11,880,000 | 11,880,000 |
| intangible assets | 6,644,000 | 6,753,000 | 1,303,000 | 1,448,000 | 1,479,000 | 99,000 | 223,000 | 348,000 | 473,000 | 599,000 | 723,000 | 848,000 | 973,000 | 1,213,000 | 1,483,000 | 1,754,000 | 2,025,000 | 2,375,000 | 2,746,000 | |||||
| deferred tax assets | 84,942,000 | 84,948,000 | 84,933,000 | 63,757,000 | 67,881,000 | 70,269,000 | 73,120,000 | 72,027,000 | 77,065,000 | 79,237,000 | 77,889,000 | 78,016,000 | 76,344,000 | 76,429,000 | 71,274,000 | 55,828,000 | 48,148,000 | 41,341,000 | 37,971,000 | |||||
| other noncurrent assets | 8,633,000 | 8,552,000 | 2,977,000 | 3,302,000 | 2,980,000 | 3,228,000 | 3,395,000 | 3,589,000 | 3,514,000 | 3,773,000 | 3,988,000 | 4,126,000 | 4,291,000 | 4,307,000 | 2,941,000 | 1,101,000 | 536,000 | 556,000 | 573,000 | 592,000 | 611,000 | |||
| total assets | 760,950,000 | 730,285,000 | 607,102,000 | 659,972,000 | 698,632,000 | 794,304,000 | 756,620,000 | 726,512,000 | 681,537,000 | 649,724,000 | 542,986,000 | 510,444,000 | 462,876,000 | 415,525,000 | 358,065,000 | 336,682,000 | 312,075,000 | 294,588,000 | 253,927,000 | 202,051,000 | 177,554,000 | 180,145,000 | 150,434,000 | 72,551,000 |
| liabilities and stockholders’ equity | ||||||||||||||||||||||||
| current liabilities: | ||||||||||||||||||||||||
| accounts payable | 140,517,000 | 145,713,000 | 95,097,000 | 130,463,000 | 151,747,000 | 130,171,000 | 125,426,000 | 132,040,000 | 130,160,000 | 145,623,000 | 109,287,000 | 104,163,000 | 92,655,000 | 84,677,000 | 61,399,000 | 55,425,000 | 54,678,000 | 57,306,000 | 43,514,000 | 42,210,000 | 31,935,000 | 39,438,000 | 19,388,000 | 23,485,000 |
| accrued expenses and other current liabilities | 79,906,000 | 91,415,000 | 73,530,000 | 78,008,000 | 73,628,000 | 75,748,000 | 60,524,000 | 61,379,000 | 63,740,000 | 61,244,000 | 50,249,000 | 52,705,000 | 52,242,000 | 44,040,000 | 37,425,000 | 49,059,000 | 44,107,000 | 43,692,000 | 34,272,000 | 31,956,000 | 25,733,000 | 19,618,000 | 16,775,000 | 17,071,000 |
| total current liabilities | 220,423,000 | 237,128,000 | 168,627,000 | 208,471,000 | 225,375,000 | 205,919,000 | 185,950,000 | 193,419,000 | 193,900,000 | 206,867,000 | 159,536,000 | 156,868,000 | 144,897,000 | 128,717,000 | 98,824,000 | 104,484,000 | 98,785,000 | 100,998,000 | 77,786,000 | 74,166,000 | 57,668,000 | 59,056,000 | 36,163,000 | 57,564,000 |
| operating lease noncurrent liabilities | 25,505,000 | 25,998,000 | 16,413,000 | 16,625,000 | 17,064,000 | 16,781,000 | 17,241,000 | 17,700,000 | 18,138,000 | 18,456,000 | 6,482,000 | 6,720,000 | 6,955,000 | 7,189,000 | 7,419,000 | 7,647,000 | 7,873,000 | 8,096,000 | 8,318,000 | |||||
| total liabilities | 245,928,000 | 263,126,000 | 185,040,000 | 225,096,000 | 242,439,000 | 222,700,000 | 203,191,000 | 211,119,000 | 212,038,000 | 225,323,000 | 166,018,000 | 163,588,000 | 151,852,000 | 135,906,000 | 106,243,000 | 112,569,000 | 107,534,000 | 109,970,000 | 86,980,000 | 74,783,000 | 57,995,000 | 59,056,000 | 36,163,000 | 57,564,000 |
| commitments and contingencies | ||||||||||||||||||||||||
| stockholders' equity | ||||||||||||||||||||||||
| common stock | 9,000 | 9,000 | 9,000 | 9,000 | 9,000 | 9,000 | 9,000 | 9,000 | 9,000 | 9,000 | 9,000 | 9,000 | 9,000 | 9,000 | 9,000 | 9,000 | 9,000 | 9,000 | 9,000 | 9,000 | 9,000 | 8,000 | 8,000 | 1,000 |
| additional paid-in capital | 642,206,000 | 611,563,000 | 581,596,000 | 551,587,000 | 519,670,000 | 489,343,000 | 461,639,000 | 438,044,000 | 408,814,000 | 379,065,000 | 349,533,000 | 323,125,000 | 300,691,000 | 278,083,000 | 255,339,000 | 242,929,000 | 240,111,000 | 238,695,000 | 236,139,000 | 234,134,000 | 231,792,000 | 231,516,000 | 228,755,000 | 18,838,000 |
| treasury stock | -303,889,000 | -303,889,000 | -303,889,000 | -250,825,000 | -188,865,000 | -27,367,000 | -1,009,000 | -1,009,000 | -1,009,000 | -1,009,000 | -1,009,000 | -1,009,000 | -1,009,000 | -1,009,000 | -1,009,000 | -1,009,000 | -1,009,000 | -1,009,000 | -1,009,000 | -1,009,000 | -1,009,000 | -1,009,000 | -1,009,000 | -1,008,000 |
| accumulated earnings | 176,478,000 | 159,366,000 | 144,307,000 | 133,775,000 | 123,354,000 | 106,869,000 | 89,971,000 | 76,501,000 | 60,603,000 | 45,612,000 | 27,934,000 | 24,526,000 | 11,315,000 | 2,547,000 | ||||||||||
| accumulated other comprehensive income | 218,000 | 110,000 | 39,000 | 330,000 | 2,025,000 | 2,750,000 | 2,819,000 | 1,848,000 | 1,082,000 | 724,000 | 501,000 | 205,000 | 18,000 | -93,000 | -312,000 | -270,000 | -50,000 | 1,000 | 17,000 | 5,000 | ||||
| total stockholders’ equity | 515,022,000 | 467,159,000 | 422,062,000 | 434,876,000 | 456,193,000 | 571,604,000 | 553,429,000 | 515,393,000 | 469,499,000 | 424,401,000 | 376,968,000 | 346,856,000 | 311,024,000 | 279,619,000 | 251,822,000 | 224,113,000 | 204,541,000 | 184,618,000 | 166,947,000 | 127,268,000 | 119,559,000 | 121,089,000 | 114,271,000 | |
| total liabilities and stockholders’ equity | 760,950,000 | 730,285,000 | 607,102,000 | 659,972,000 | 698,632,000 | 794,304,000 | 756,620,000 | 726,512,000 | 681,537,000 | 649,724,000 | 542,986,000 | 510,444,000 | 462,876,000 | 415,525,000 | 358,065,000 | 336,682,000 | 312,075,000 | 294,588,000 | 253,927,000 | 202,051,000 | 177,554,000 | 180,145,000 | ||
| accounts receivable, net of 58,610 and 56,355 of allowance at march 31, 2025 and december 31, 2024, respectively | 299,743,000 | |||||||||||||||||||||||
| accounts receivable, net of 56,355 and 46,636 of allowances at december 31, 2024 and 2023, respectively | 235,324,000 | |||||||||||||||||||||||
| accounts receivable, net of 55,671 and 46,636 of allowances at september 30, 2024 and december 31, 2023, respectively | 280,724,000 | |||||||||||||||||||||||
| stockholders’ equity | ||||||||||||||||||||||||
| accounts receivable, net of 54,081 and 46,636 of allowances at june 30, 2024 and december 31, 2023, respectively | 293,796,000 | |||||||||||||||||||||||
| accounts receivable, net of 50,054 and 46,636 of allowances at march 31, 2024 and december 31, 2023, respectively | 297,209,000 | |||||||||||||||||||||||
| accounts receivable, net of 46,636 and 28,328 of allowances at december 31, 2023 and 2022, respectively | 241,869,000 | |||||||||||||||||||||||
| accounts receivable, net of 42,896 and 28,328 of allowances at september 30, 2023 and december 31, 2022, respectively | 268,766,000 | |||||||||||||||||||||||
| accounts receivable, net of 37,892 and 28,328 of allowances at june 30, 2023 and december 31, 2022, respectively | 264,958,000 | |||||||||||||||||||||||
| accounts receivable, net of 33,447 and 28,328 of allowances at march 31, 2023 and december 31, 2022, respectively | 313,245,000 | |||||||||||||||||||||||
| accounts receivable, net of 28,328 and 17,379 of allowances at december 31, 2022 and 2021, respectively | 240,067,000 | |||||||||||||||||||||||
| accounts receivable, net of 27,197 and 17,379 of allowances at september 30, 2022 and december 31, 2021, respectively | 258,035,000 | |||||||||||||||||||||||
| accounts receivable, net of 23,476 and 17,379 of allowances at june 30, 2022 and december 31, 2021, respectively | 229,864,000 | |||||||||||||||||||||||
| | ||||||||||||||||||||||||
| accounts receivable, net of 19,660 and 17,379 of allowance at march 31, 2022 and december 31, 2021, respectively | 198,120,000 | |||||||||||||||||||||||
| accumulated other comprehensive loss | -11,000 | |||||||||||||||||||||||
| accounts receivable, net of 17,379 and 9,502 of allowances at december 31, 2021 and 2020, respectively | 134,557,000 | |||||||||||||||||||||||
| other noncurrent liabilities | 438,000 | 876,000 | 876,000 | 876,000 | 617,000 | 327,000 | ||||||||||||||||||
| accumulated deficit | -2,424,000 | -17,504,000 | -34,300,000 | -53,027,000 | -68,193,000 | -105,883,000 | -111,238,000 | -109,426,000 | -113,483,000 | -109,081,000 | ||||||||||||||
| accounts receivable, net of 16,130 and 9,502 of allowance at september 30, 2021 and december 31, 2020, respectively | 135,181,000 | |||||||||||||||||||||||
| accounts receivable, net of 14,105 and 9,502 of allowance at june 30, 2021 and december 31, 2020, respectively | 140,767,000 | |||||||||||||||||||||||
| accounts receivable, net of 11,818 and 9,502 of allowance at march 31, 2021 and december 31, 2020, respectively | 116,666,000 | |||||||||||||||||||||||
| accounts receivable, net of 16,199 and 6,320 of allowances at december 31, 2020 and december 31, 2019, respectively | 75,664,000 | |||||||||||||||||||||||
| accounts receivable, net of 12,631 and 6,320 of allowances at september 30, 2020 and december 31, 2019, respectively | 78,302,000 | |||||||||||||||||||||||
| accounts receivable, net of 11,084 and 6,320 of allowances at june 30, 2020 and december 31, 2019, respectively | 64,996,000 | |||||||||||||||||||||||
| accounts receivable, net of 8,477 and 6,320 of allowances at march 31, 2020 and december 31, 2019, respectively | 65,862,000 | |||||||||||||||||||||||
| other assets | 629,000 | 652,000 | 3,614,000 | |||||||||||||||||||||
| accounts receivable, net of 6,320 and 3,486 of allowances at december 31, 2019 and december 31, 2018, respectively | 47,059,000 | |||||||||||||||||||||||
| assets of discontinued operations, current | ||||||||||||||||||||||||
| liabilities, convertible preferred stock and stockholders’ equity | ||||||||||||||||||||||||
| convertible preferred stock warrant liabilities | 17,008,000 | |||||||||||||||||||||||
| short term debt | ||||||||||||||||||||||||
| convertible preferred stock (note 12), 0.0001 par value; 100,000,000 and 314,930,070 shares authorized as of december 31, 2019 and december 31, 2018; zero and 65,428,088 shares issued and outstanding at december 31, 2019 and december 31, 2018, respectively; aggregate liquidation preference of 0 and 106,369 as of december 31, 2019 and december 31, 2018, respectively | ||||||||||||||||||||||||
| total liabilities, convertible preferred stock, and stockholders’ equity | 150,434,000 | |||||||||||||||||||||||
| accounts receivable, net of 7,582 and 3,486 of allowances at september 30, 2019 and december 31, 2018, respectively | 44,337,000 | |||||||||||||||||||||||
| liabilities, convertible preferred stock and stockholders’ deficit | ||||||||||||||||||||||||
| convertible preferred stock | 106,237,000 | |||||||||||||||||||||||
| stockholders' deficit | ||||||||||||||||||||||||
| total stockholders’ deficit | -91,250,000 | |||||||||||||||||||||||
| total liabilities, convertible preferred stock, and stockholders’ deficit | 72,551,000 | |||||||||||||||||||||||
| revenue | 61,196,000 | |||||||||||||||||||||||
| cost of services | 48,876,000 | |||||||||||||||||||||||
| gross profit | 12,320,000 | |||||||||||||||||||||||
| operating expenses: | ||||||||||||||||||||||||
| sales and marketing | 3,183,000 | |||||||||||||||||||||||
| general and administrative | 6,068,000 | |||||||||||||||||||||||
| total operating expenses | 9,251,000 | |||||||||||||||||||||||
| income from continuing operations | 3,069,000 | |||||||||||||||||||||||
| other income: | ||||||||||||||||||||||||
| interest expense | -28,000 | |||||||||||||||||||||||
| convertible preferred stock warrant valuation adjustment | -11,226,000 | |||||||||||||||||||||||
| total other income | -11,254,000 | |||||||||||||||||||||||
| income from continuing operations, before tax | -8,185,000 | |||||||||||||||||||||||
| benefit for income taxes | -25,000 | |||||||||||||||||||||||
| net income from continuing operations | -8,210,000 | |||||||||||||||||||||||
| net income from discontinued operations, net of taxes | ||||||||||||||||||||||||
| net income and comprehensive income | -8,210,000 | |||||||||||||||||||||||
| net income attributable to common stockholders | -8,210,000 | |||||||||||||||||||||||
| net earnings per share attributable to common stockholders: | ||||||||||||||||||||||||
| basic and diluted | 7,472,469,000 | |||||||||||||||||||||||
| continuing operations | -1,100 | |||||||||||||||||||||||
| discontinued operations | ||||||||||||||||||||||||
| total net earnings per share attributable to common stockholders basic and diluted | -1,100 | |||||||||||||||||||||||
| weighted-average shares used for eps calculation |
We provide you with 20 years of balance sheets for Progyny stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as asset and liabilities, payables and receivables, long debts and short debts, cash and inventories, expenses and profits. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Progyny. Explore the full financial landscape of Progyny stock with our expertly curated balance sheets.
The information provided in this report about Progyny stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.